Epizyme, Inc. Soared

Mon, Jun 27, 2022 at 08:30 PM
Epizyme, Inc. Soared

Epizyme, Inc. (EPZM:NASDAQ) shot up at $1.48, representing a gain of 55.1%. On Mon, Jun 27, 2022, EPZM:NASDAQ touched a New 2-Week High of $1.48. The stock appeared on our News Catalysts scanner on Mon, Jun 27, 2022 at 06:32 PM in the 'ACQUISITION' category. From Mon, Jun 13, 2022, the stock recorded 66.67% Up Days and 60.00% Green Days

About Epizyme, Inc. (EPZM:NASDAQ)

Epizyme Inc is a clinical stage biopharmaceutical company. The Company discovers, develops and commercializes novel epigenetic therapies for cancer patients.

Share
Get 50% Off Premium Subscription
$19.99 USD
Limited-Time Discount
$9.99 USD
monthly
Signup 7 Days Trial. No Credit Card Required!
Ever wanted to explore stocks that have recently spiked... stocks moving sideways... gaps... or other trends? You're in the right place! Check StockTreats features.